Tag Archives: PostCOVID

Spending on Medicines In and Post-COVID Say a Lot About Patients and Larger Healthcare Trends – an IQVIA Update

Spending on medicines, globally, will rebound this year and rise above pre-pandemic levels through 2025. Between 2021 and 2025, the annual growth global growth rate for prescription drugs spending is expected to range from 3% to 6%, a $ 1.6 trillion bill for the worlds’s total Rx medicines market. That relatively low single-digit growth rate… Read More »

The Post-COVID 19 Health Consumer: Ready for DIY Health Care and More Open to Telehealth

The COVID-19 pandemic has re-shaped consumers for work, school, fitness, cooking, and certainly for health care. PwC’s Health Research Institute has combed through their consumer survey data and developed insights on health consumers, shared in a summary titled Consumer health behavior and the COVID-19 pandemic: What we’ve learned. Most U.S. consumers would be likely to… Read More »